Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Long-Term Results From the AGILE Study of Azacitidine Plus Ivosidenib vs Placebo in Newly Diagnosed IDH1-Mutated AML, Pau Montesinos, Dylan M Marchione, Christian Recher, et al.
Prediction of Grade 4 Radiation-Induced Lymphopenia During Chemoradiation Therapy for Lung Cancer Patients: Insights From Two Past Trials, Serena Monti, Giuseppe Palma, Ting Xu, et al.
A Virtual Wellness Program to Enhance Well-being for Pediatric Oncology Staff during the COVID-19 Pandemic, Karen M Moody, Maria Chang Swartz, Zachary Gresham, et al.
Microbial Signals in Primary and Metastatic Brain Tumors, Golnaz Morad, Ashish V Damania, Brenda Melendez, et al.
Diet-Enhanced LRG1 Expression Promotes Insulin Hypersecretion and Er Stress in Pancreatic Beta Cells, Desirae D Morales, Jiyoon Ryu, Cong Wei, et al.
Designing an Electronic Patient-Reported Outcomes Information Infrastructure Supported by the RE-AIM Implementation Framework, Amy C Moreno, Angela Peek, Toshiko S Stein, et al.
International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study, Amy C Moreno, Erin E Watson, Laia Humbert-Vidan, et al.
Stiefel MD Anderson OroPharynx Cancer (Mda-Opc) Cohort: A Single-Institution, Prospective Longitudinal Outcomes Study, Amy Moreno, Ariana J Sahli, Faye Johnson, et al.
Single-Cell Analysis of Neoplastic Plasma Cells Identifies Myeloma Pathobiology Mediators and Potential Targets, Luz Yurany Moreno Rueda, Hua Wang, Keiko Akagi, et al.
Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG), Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG), Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Structural Insights Into Light-Gating of Potassium-Selective Channelrhodopsin, Takefumi Morizumi, Kyumhyuk Kim, Hai Li, et al.
DNA Damage Response Signatures Are Associated With Frontline Chemotherapy Response and Routes of Tumor Evolution in Extensive Stage Small Cell Lung Cancer, Benjamin B Morris, Simon Heeke, Yuanxin Xi, et al.
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal, Van K Morris, Suyu Liu, Kangyu Lin, et al.
Phase 1/2 Trial of Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E Metastatic Colorectal Cancer, Van K Morris, Christine M Parseghian, Vahid Bahrambeigi, et al.
Phase 1/2 Trial of Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E Metastatic Colorectal Cancer, Van K Morris, Christine M Parseghian, Vahid Bahrambeigi, et al.
Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer, Van K Morris, Weihong Xiao, Kangyu Lin, et al.
Proceedings of the National Cancer Institute Workshop on Combining Immunotherapy With Radiotherapy: Challenges and Opportunities for Clinical Translation, Zachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
The Effect of Chronic Azithromycin Use in Winter on Health Care Utilization for Children With Bronchopulmonary Dysplasia: A Double Blind Randomized Controlled Study (RCT), Ricardo A Mosquera, Aravind Yadav, Maria Del Mar Romero-Lopez, et al.
Identification of Prothrombin Belgrade Variant in a Mexican-American Family with Recurrent Deep Vein Thrombosis, Émile Moura Coelho da Silva, Natalie Montanez, and Miguel Escobar
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Metastatic Variant Histology (Non-Clear Cell) Renal Cell Carcinoma, Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract, Mohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, et al.
Identification of Therapeutic Targets for Renal Medullary Carcinoma via Integrated Genomic and Transcriptomic Profiling, Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Sitravatinib in Combination With Nivolumab Plus Ipilimumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: A Phase 1 Trial, Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers, Mohd Mughees, Moises Tacam, Alex W Tan, et al.